Influence of Boron Neutron Capture Therapy on Normal Liver Tissue

Radiat Res. 2022 Oct 1;198(4):368-374. doi: 10.1667/RADE-22-00018.1.

Abstract

Radiation-induced liver diseases, including liver fibrosis, occurs when radiation damages the liver. Basic research on hepatic fibrosis, which is a late radiation injury, is necessary for evaluating adverse liver events occurring after boron neutron capture therapy. This study was conducted to establish a method for analyzing the negative effect such as fibrosis in the liver tissue after boron neutron capture therapy. Female C57BL6 mice were injected with p-boronophenylalanine solution subcutaneously at 2 h before neutron irradiation. Masson trichrome staining was performed to determine the degree of liver fibrosis. The degree of fat accumulation in mouse normal liver tissue after boron neutron capture therapy was evaluated using hematoxylin and eosin staining and triglyceride quantification. Western blotting was performed to determine the expression level of Sonic Hedgehog. Liver fat accumulation and fibrosis were significantly increased in the neutron irradiation group injected with p-boronophenylalanine compared with control group. In addition, Sonic Hedgehog expression was increased in response to boron neutron capture therapy-induced liver injury and was involved in liver fibrosis. Hepatocellular fat accumulation and Hedgehog signaling activation may be indicators of adverse events related to boron neutron capture therapy associated with liver fibrosis.

MeSH terms

  • Animals
  • Boron Compounds
  • Boron Neutron Capture Therapy* / adverse effects
  • Boron Neutron Capture Therapy* / methods
  • Eosine Yellowish-(YS)
  • Female
  • Fibrosis
  • Hedgehog Proteins
  • Hematoxylin
  • Liver Cirrhosis
  • Mice
  • Mice, Inbred C57BL
  • Phenylalanine / analogs & derivatives
  • Triglycerides

Substances

  • Boron Compounds
  • Hedgehog Proteins
  • Triglycerides
  • Phenylalanine
  • Eosine Yellowish-(YS)
  • 4-boronophenylalanine
  • Hematoxylin